Skip to content

Study on symptoms and medication use in the patiants with grass pollinosis, and grass pollen counts

Study on symptoms and medication use in the patiants with grass pollinosis, and grass pollen counts

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030230670
Enrollment
200
Registered
2024-02-29
Start date
2024-03-04
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grass pollinosis

Interventions

None listed

Sponsors

Kikuchi Masayo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Male and female patients over 5 years old and under 65 years old on the day of informed consent (2)Patients with moderate or severe nasal symptoms of nasal discharge, nasal congestion, sneezing, or itching or eye symptoms of foreign body sensation in eyes/hyperemia/itching or lacrimation outside the house (particularly in the places where weeds can be seen, such as riverbeds, fields, rice paddies, open spaces, etc.), and with requirement of medication therapy, during the recent grass pollen season (May to August) (3)Patients who may be able to appropriately enter their condition of pollinosis in the electronic diary by smartphone or tablet device (the parents when patients are aged < 12 years on the day of informed consent)

Exclusion criteria

Exclusion criteria: (1)Patients who received specific immunotherapy for Grass, Cypress, Birch, Alder, Ragweed, Mugwort or Japanese Hop pollinosis for at least 1 month from within 5 years prior to the day of first observation (Visit 1) to the day of second observation (Visit 2) (2)Patients who received laser treatment or surgery for the treatment of nasal symptoms from within 1 years prior to the day of first observation (Visit 1) to the day of second observation (Visit 2) (3)Patients who are unlikely to complete the study or who are expected to change their living environment during the study period (e.g., moving and lifestyle changes such as higher education and employment)

Design outcomes

Primary

MeasureTime frame
From May to August, Rhinoconjunctivitis Symptom Score, Rhinoconjunctivitis Madication Score, Total Rhinoconjunctivitis Symptom and Madication Score, Proportion of the subjects used medication for symptom of pollinosis, and the daily each pollen counts from May to August, pollen are Grass, Cypress, Birch, Alder, Ragweed, Mugwort, Japanese Hop.

Contacts

Public ContactMasayo Kikuchi

Torii Pharmaceutical Co.,Ltd

cdcr_jrct@torii.co.jp+81-3-3231-6811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026